Dr. Jerry Tan

Dermatologist, Windsor, ON

Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan. His general dermatology and aesthetic dermatology practices are in Windsor Ontario Canada. He conducts clinical trials research at Windsor Clinical Research, a clinical trials site in dermatology. Aside from industry grants, he has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.

Research focus includes acne, acne scars and rosacea. Additional interests include outcome measurements and informed shared decision making in dermatology. We have developed 3 patient decision aids in dermatology – acne, psoriasis and hidradenitis suppurativa – available at www.informed-decisions.org

Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. Over the past 3 decades, Dr. Tan has authored/co-authored more than 100 peer-reviewed publications.

9:45 AM - 10:00 PM Plenary Session 1

Nov 24

Optimizing Outcomes in Acne Management

In a medical encounter, there are two experts: the clinician, expert in disease and its management and the patient, expert in illness and their own circumstances. A therapeutic relationship is a journey recognizing the expertise of both. This presentation addresses practical aspects of initiating the acne care pathway representing the what, why, when and how aspects of treatment.

Learning objectives:

  1. Understand how to engage patients in a brief acne consultation
  2. List the critical questions that help direct your acne management plan
  3. Discuss essential aspects to explain at treatment initiation
10:15 AM - 10:25 AM Plenary Session 1

Nov 24

Questions & Answers

11:55 AM - 12:25 PM Open Presentation

Nov 24

New evidence supporting the benefits of ceramide-containing cleansers and moisturizers as adjunct therapy in acne vulgaris

Learning Objectives:

  1. Explore skin barrier dysfunction in acne
  2. Discuss the benefits and challenges of effective RX therapy in acne
  3. Present new data showcasing the benefits of ceramide-containing adjunct therapy

Summary/description of the session:
Skin barrier dysfunction plays a role in the pathology, development and severity of acne. Topical acne prescription therapy, while effective, can cause further damage to the skin barrier and lead to irritation and can negatively affect patient treatment adherence. In this presentation, new clinical evidence supporting the benefits of using ceramide-containing cleansers and moisturizers as adjunct therapy will be demonstrated.

4:45 AM - 5:15 PM Joint Derm Update & SRG Session

Nov 24

Does seasonal variation impact the efficacy and safety/tolerability of a new topical retinoid in acne management?

Learning Objectives:

  1. Discuss the significance of the Polymeric Emulsion Vehicle Technology in topical retinoid formulation.
  2. Analyse the impact of winter and summer seasons on the efficacy and tolerability of a new topical retinoid formulation in acne management.

12:15 PM - 2:15 PM Advisory Board

Nov 25

Sun Pharma Acne National Advisory Board